Document Detail


Effect of the method of conception and embryo transfer procedure on mid-gestation placenta and fetal development in an IVF mouse model.
MedLine Citation:
PMID:  20576634     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Abnormal placentation is a potential mechanism to explain the increased incidence of low birthweight observed after IVF. This study evaluates, in a mouse model, whether the method of conception and embryo transfer affect placentation and fetal development.
METHODS: IVF blastocysts (CF1 x B6D2F1/J) were cultured in Whitten's medium (IVF(WM), n = 55) or K modified simplex optimized medium with amino acids (IVF(KAA), n = 56). Embryos were transferred to the uteri of pseudo-pregnant recipients. Two control groups were created: unmanipulated embryos produced by natural mating (in vivo group, n = 64) and embryos produced by natural mating that were flushed from uterus and immediately transferred to pseudo-pregnant recipients (flushed blastocysts, FB group, n = 57). At gestation age 12.5 days, implantation sites were collected and fixed; fetuses and placentas were weighed and their developmental stage (DS) evaluated. Placental areas and vascular volume fractions were calculated; parametric statistics were applied as appropriate.
RESULTS: IVF fetuses showed a modest but significant delay in development compared with FB mice (P < 0.05). In addition, IVF conceptuses were consistently smaller than FB (P < 0.05). Importantly, these differences persisted when analyzing fetuses of similar DS. The placenta/fetus ratio was larger in the IVF group (IVF(WM) 0.95; IVF(KAA) = 0.90) than the FB group (0.72) (P < 0.05 for all comparisons). Gross morphology of the placenta and ratio labyrinth/fetal area were equivalent in the IVF and FB groups, as were percentage of fetal blood vessels, maternal blood spaces and trophoblastic components.
CONCLUSIONS: In vitro embryo culture affects fetal and placental development; this could explain the lower birthweight in IVF offspring.
Authors:
L Delle Piane; W Lin; X Liu; A Donjacour; P Minasi; A Revelli; E Maltepe; P F Rinaudo
Related Documents :
22924494 - Noninvasive prenatal diagnosis of down syndrome in samples from southwest chinese gravi...
7512054 - High continuing pregnancy rates after in vitro fertilization-embryo transfer using medi...
19296944 - Delayed delivery following unusual flare-up pelvic abscess after in vitro fertilization...
18363004 - A cumulative embryo scoring system for the prediction of pregnancy outcome following in...
332324 - Consequences of acute myelogenous leukemia in early pregnancy.
3169634 - Screening in pregnancy with unconjugated serum estriol compared with urinary estriol.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2010-06-24
Journal Detail:
Title:  Human reproduction (Oxford, England)     Volume:  25     ISSN:  1460-2350     ISO Abbreviation:  Hum. Reprod.     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-07-21     Completed Date:  2010-11-23     Revised Date:  2011-08-03    
Medline Journal Info:
Nlm Unique ID:  8701199     Medline TA:  Hum Reprod     Country:  England    
Other Details:
Languages:  eng     Pagination:  2039-46     Citation Subset:  IM    
Affiliation:
Obstetric, Gynecology and Reproductive Science Division, University of California San Francisco, San Francisco, CA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Birth Weight
Embryo Culture Techniques
Embryo Transfer / methods*
Female
Fertilization in Vitro / adverse effects,  methods*
Fetal Development*
Gestational Age
Mice
Models, Animal
Placenta / growth & development*,  pathology
Placentation*
Pregnancy
Grant Support
ID/Acronym/Agency:
1U54HD055764/HD/NICHD NIH HHS
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of different inspired oxygen fractions on lipid peroxidation during general anaesthesia for ...
Next Document:  OCT4 expression in human uterine myometrial stem/progenitor cells.